Genfit - ADR - Tradey

Genfit - ADR

The momentum for this stock is not very good. Genfit - ADR is not a good value stock. Genfit - ADR is not a good growth stock. Genfit - ADR is not very popular among insiders. Tradey thinks it is not wise to invest in Genfit - ADR.

Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early di...

News

Genfit (GNFTF) Gets a Buy from Kepler Capital

TipRanks Financial Blog Kepler Capital analyst Justine Telliez maintained a Buy rating on Genfit (GNFTF - Research Report) on August 27 and set a price target of €8.40. Th...\n more…

Genfit (NASDAQ:GNFT) Stock Price Down 0.2%

Ticker Report Genfit S.A. (NASDAQ:GNFT - Get Free Report)'s stock price was down 0.2% during trading on Monday . The stock traded as low as $4.15 and last traded at $4.26. Approximately 8,318 shares traded hands...\n more…

Genfit (NASDAQ:GNFT) Given "Buy" Rating at HC Wainwright

Ticker Report HC Wainwright reiterated their buy rating on shares of Genfit (NASDAQ:GNFT - Free Report) in a research note released on Monday, Benzinga reports. They currently have a $13.00 price target on the...\n more…

GENFIT's Drug Nears EU Market Approval

TipRanks Financial Blog Genfit SA (GNFT) has released an update. GENFIT, a biopharmaceutical company, announced the European Medicines Agency's positive opinion on Ipsen's Iqirvo® (elafibr...\n more…

Genfit announces positive CHMP opinion for Ipsen's Iqirvo

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Genfit S.A. (NASDAQ:GNFT) Short Interest Update

Zolmax Genfit S.A. (NASDAQ:GNFT - Get Free Report) was the target of a large growth in short interest in June. As of June 15th, there was short interest totalling 96,300 shares, a growth of 7.2% from the...\n more…